Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients

Journal of Viral Hepatitis

Volumn 9, Issue 3, 2002, Pages 229-234

  Sung, Joseph J Y ^a,b   Chan, H L Y ^a   Wong, M L ^a   Tse, C H ^a   Yuen, S C H ^a   Tam, J S L ^a   Leung, N W Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Genotype; HBeAg; HBV DNA; Hepatitis B virus; Transaminase

Indexed keywords

ALKALINE PHOSPHATASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ACUTE HEPATITIS; ADULT; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; REMISSION; RISK FACTOR; STOP CODON; TREATMENT OUTCOME; VIROLOGY; VIRUS MUTATION;

ADULT; ALANINE TRANSAMINASE; ALGORITHMS; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; PREDICTIVE VALUE OF TESTS;

EID: 0036916045     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00352.x     Document Type: Article

References (27)

1. Fattovich G, Rugge M, Brollo L et al. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986; 6: 167-172.
2. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Hepatology 1988; 8: 493-496.
3. Marco VD, Iacono OL, Camma C et al. The long-term course of chronic hepatitis B. Hepatology 1999; 30: 257-264.
4. Tassopoulos NC, Volpes R, Pastore G et al. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/ hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Hepatology 1999; 29: 889-896.
5. Hadziyannis SJ, Papatheodoridis GV, Dimou E, Laras A, Papaioannou C. Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2000; 32: 847-851.
6. Chan HLY, Hui Y, Leung NWY, Ching JYL, Chan FKL, Sung JJY. Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus-infected patients. Am J Gastroenterol 2000; 95: 3547-3551.
7. Scaglioni PP, Melegari M, Wands JR. Biologic properties of hepatitis B viral genomes with mutations in the precore promotor and precore open reading frame. Virology 1997; 233: 374-381.
8. Buckwood VE, Xu Z, Chen M, Yen TSB, Ou J-H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promotor on precore gene expression and viral replication. J Virol 1996; 70: 5845-5851.
9. Moriyama K, Okamoto H, Tsuda F, Mayumi M. Reduced precore transcription and enhanced core-pregenomic transcription of hepatitis B virus DNA after replacement of the precore-core promotor with sequences associated with e antigen-seronegative persistent infections. Virology 1996; 226: 269-280.
10. Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutation in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-1704.
11. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben-Porath E. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 1991; 324: 1705-9.
12. Sato SS, Suzuki K, Akahane Y et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 241-248.
13. Chan HLY, Leung NWY, Hussain M, Wong ML, Lok ASF. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 2000; 31: 763-768.
14. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotype correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000; 118: 554-559.
15. Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987; 92: 1839-1843.
16. Lai VCH, Guan R, Wood ML, Lo SK, Yuen MF, Lai CL. Nucleic acid-based cross-linking assay for detection and quantification of hepatitis B virus DNA. J Clin Microbiol 1999; 37: 161-164.
17. Chan HLY, Leung NWY, Lau TCM, Wong ML, Sung JJY. Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy. J Clin Microbiol 2000; 38: 3205-3208.
18. Chan HLY, Hussain M, Lok ASF. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during HBeAg seroconversion. Hepatology 1999; 29: 976-984.
19. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus - Large-scale analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-1293.
20. Maruyama T, Iino S, Koike K, Yasuda K, Milich DR. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology 1993; 105: 1141-1151.
21. Chan HLY, Leung NWY, Liew CT et al. Core promoter and precore stop codon mutations are not associated with more severe liver damage in HBeAg negative chronic hepatitis B. Hepatology 2000; 32: 449A.
22. ter Borg F, ten Kate FJW, Cuypers HTM et al. Relation between laboratory test results and histological hepatitis activity in individuals positive for hepatitis B surface antigen and antibodies to hepatitis B antigen. Lancet 1998; 351: 1914-1918.
23. Lok ASF, Hadziyannis SJ, Weller IVD et al. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. Gut 1984; 25: 1283-1287.
24. Lindh M, Horal P, Dhillon AP et al. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatiits B. J Viral Hepatitis 2000; 7: 258-267.
25. Orito E, Mizokami M, Sakugawa H et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotype B and C. Hepatology 2001; 33: 218-323.
26. Brunetto MR, Giarin MM, Oliveri F et al. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 1991; 88: 4186-4190.
27. Lai ME, Solinas A, Mazzoleni AP et al. The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study. J Hepatol 1994; 20: 773-781.